Biotech

All Articles

OS Treatments refiles $6M IPO to money HER2 medication, preclinical ADCs

.Operating system Therapies are going to note on the NYSE American stock exchange this morning via a...

ALX's waning CD47 feedback rate sends supply spiraling down

.ALX Oncology's period 2 stomach cancer response price has actually deteriorated. After finding its ...

Ionis axes eye condition from intendeds of Roche-partnered possibility after information dissatisfy

.Yet Another of Ionis Pharmaceuticals' key midphase readouts has disappointed expectations, promptin...

Biogen's chief executive officer mentioned no dangerous sell 2023. He's ready to be bold

.While Biogen's pharma peers are looking for late-stage resources along with little bit of risk, CEO...

Instil refills pipe in $2B biobucks deal with ImmunOnco

.Instil Bio has been a biotech searching for a pipe after it ditched its lead assets over the final ...

Biogen walks away from Denali Alzheimer's collab

.Biogen has actually restored rights to a very early Alzheimer's condition program to Denali Rehabs,...

Takeda touches brand new head of US oncology service-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings and...

Vertex, beaten through AATD once again, loses 2 assets on throw away pile

.Vertex's try to address an unusual hereditary disease has struck another problem. The biotech shook...

Vir gains 3 T-cell engagers from Sanofi, lays off 25% of staff

.Vir Medical's second-quarter profits report had not been except major updates. The provider accepte...

Galapagos pauses CAR-T cell treatment litigation over Parkinsonism instance

.Galapagos has paused registration in a test of a BCMA-directed CAR-T tissue treatment, pushing the ...